IPSC Breakout Session #1

Too much to choose from; I prioritized things that were new
to me.

Mark Bartholomew, A Right to Be Left Dead

If we can create new works in a dead author’s style after
they’re gone and create conversations with them (including loved ones) after
gone, and populate new entertainment with dead actors, isn’t that something
new? NY State created a postmortem right of publicity specifically for computer-generated
likenesses; Louisiana did so too. IP Subcommittee on AI: was a lot about
whether we need a national ROP to deal with this. Wants to focus on the
relevance of death.

How do other areas of law treat relevance of death? Map onto
3 main rationales for ROP.

Dignitary interests: false light, IIED, privacy typically
expire w/person. There is some exception for actions immediately surrounding death
or moment of burial. Death closes things off.

Consumer protection: laws meant to protect consumers, death
doesn’t matter—Princess Diana’s image on collectible plates—TM claim was maintainable.
So too w/false advertising. Makes sense b/c consumer protection law’s goal is
information safety and not vindicating rights of decedent.

Property law: somewhere between all and nothing. Decedent’s
operative intent to extinguish property right—when you bury people w/jewelry by
their choice, no estate tax; it just disappears. Body parts. Forced share laws
for spouses. To fix suboptimal postmortem allocations.

Need and precedent: how is AI being used to reanimate
people? One use is grieving: used to create a chatbot w/specific person corresponding
to a past entity. Advertising: false endorsement potential. Actors’ strike is in
part about who controls past performances if they’re being used to populate new
media productions? Great deal of variability in postmortem ROP. Okla and Indiana
give 100 years, potentially infinite in Tennessee. Entertainment: stronger ground
to articulate right in performances; incentive story makes more sense for this
than for other invocations of right of identity. Stare decisis: can we really
fight this any more?  We can at least
fight how we structure the rules of postmortem ROP when it’s only found in
about half the states.

Solutions: better ways to articulate postmortem wishes,
including a way to abandon postmortem publicity rights. Putting it in a trust like
Robin Williams did might not be enough—might be fiduciary duty to use it
commercially.

Duration: goal is to recreate original; the right shouldn’t
extend long past death, because the key is generational change/asserting
difference from previous one is a key mechanism.

Prior exploitation requirement? Need to have used identity
commercially during life in order to trigger postmortem right. Death is a
demarcation point in many circumstances; we should have a mechanism for free
use for research and other purposes for most people who didn’t have opportunity
to commercially leverage persona during life.

Fred Yen: why analyze things through interests of dead
person at all? Couldn’t we look at it through the interests of the living? Grief
trolls—sending a person messages from deceased loved ones would be IIED; copyright
can handle performances, collective bargaining can handle digital models in
Hollywood. There’s lots of reasons to keep the dead from having too much
influence over our lives.

Mark McKenna: many recent issues over use of personality after
death would have been unanticipated during their lifetimes. How practical is it
to imagine needing affirmative steps to anticipate those uses? Why not just a
set of defaults?

[My thoughts: Intro sounded to me like classic anxieties
over what currently seems like realistic tech of representation—putting words
in mouth that never said happened in written word, in print, in image, in
cartoon, and there have been repeated moral panics about how everyone will
perceive these as real/deceptive; we just keep resetting our expectations.]

Consumer protection/TM: why would ordinary consumers care
about consent of estate or believe there was unified control? And why would
endorsement of estate equate to endorsement of celebrity in consumer’s mind?
Assumptions skipped over in TM/false advertising analysis.]

Lucas Osborn, Christianity & IP

Core: creation, Fall, redemption, restoration. Genesis: G-d
said, “Let us make man in our image, after our likeness. And let
them have dominion over … all the earth.” Humans are categorically
different from other animals and have some special relationship to G-d, our
creator; we have a purpose in the world. Thus, we are created with creative tendencies/desires
to create.

But all is not well because of the Fall. We also have a
tendency to sin. The legal construct we use for that is the wealth maximizer,
who maximizes their own happiness. We also sometimes act irrationally b/c our
reasoning is messed up. Nonetheless there is still goodness in the world. That
can map onto behavioral law & economics. We will not always act justly or
see correctly what the just thing is to do.

Humans will generally not create at maximum potential or
create things for the common good or use creation in a just way—incentives may
be able to intervene here. Example: drugs that are overpriced; but even within
Christian worldview, fallen humanity may require attending to incentives.

Deborah Gerhardt: Tree of knowledge is part of the Fall. Jewish
theology sees this as opportunity to do good, to choose good or evil, a
maturation of knowledge. We wouldn’t need rules if there was no difference.

Jeremy Sheff: Spread of knowledge—evangelical perspectives
may differ from nonevangelical. Catholic tradition about authority over congregation/knowledge
is very different. Control over text is part of some traditions, along with
control of knowledge that might conflict with or comment on the text. Can you
separate those issues from the theological issues? IP is as much about distribution
of knowledge as it is about creation.

Dustin Marlan, Trademark Disclosure

TM registration requires disclosures just as patent does:
undertheorized. First use/use in commerce date, drawing of mark, goods and
services, owner, domicile.  Why? Protecting
brand investment and consumers?

The TM bargain: registration can be made in a form prescribed
by the Director, so there’s some statutory flexibility if we think policy justifies
it. Specimens: one per class, as currently required.

Benefits: nationwide right of priority, evidence of
validity/exclusive ownership, right to police imports, incontestability after 5
years, symbolic benefits like ®. Constructive notice to the public is often
thought of as good, but it can put the claimant on the radar (as trade secrecy
is an alternative to patent)—people could find you and send you a C&D;
admissions could be detrimental in later LOC analysis, e.g. conceding to a disclaimer;
might want to file in a jurisdiction without disclosure like Trinidad &
Tobago to avoid tipping off the market; icky mark or brand could be unpalatable
to the public.

Could TM disclosures be tweaked to make them more
consumer-friendly? TESS is a mess. Could it be more consumer-friendly to allow
more comprehensibility to the lay public?

RT: not sure that disclaimers ever matter to future rights,
but collateral estoppel/B&B is a big deal now, as is the loss of potential
defenses after Jack Daniels. Also I’m not sure that you can ever make
registration an engine of consumer protection b/c people never look up classes,
first use date, etc.

Justin Hughes: analogy to patent applications—written description
and enablement are quite different. Classes/goods and services might be the closest
analogy to metes and bounds.

Mark McKenna: natural to think about goods & services as
description of claim in a world where the claim is for a word mark; the
boundaries were clearer for Nike. But many other applications are less clear
for what they are, and we need more rules around that. Courts don’t follow
PTO rules about dotted lines; they aren’t careful about what the mark consists
of or comprises, especially to get to inherent distinctiveness. That’s where
disclosure rules need the most attention: definition and relation to what
courts are going to do with the registration.

Alex Roberts: Different reasons to choose not to use system—stealth
registrations in T&T are different versus “we define trade dress when we
choose to sue over near copies”; Mattel enforces a lot against pink but doesn’t
register it so it doesn’t have to define a specific color.

Bartholomew: Registration is optional, not mandatory as with
patents; is this the right number of sweeteners to encourage people to register?

Hughes: could compare cases where they narrow the claim of
the TM registration v. narrow the claim of the patent—Maker’s Mark case where
they have a registration for a wax seal but claim only red.

McKenna: and the reverse, where they register narrowly but
claim broadly.

Matthew Sipe: connection here with Katyal’s project where
public doesn’t get everything it needs for full agency in consumption.

Elizabeth Townsend Gard: people don’t register color as trade
dress—interesting to consider why not. Same with word marks—they register
standard word mark when color is an important part of what they’re doing.

Lorelei Ritchie, is this generic 😦 ?

Consumer perceptions need evidence—surveys, declarations,
dictionaries. Consumer perceptions change over time. Can a generic term be
ungenericized? After Booking.com, maybe it can be because consumer perception
is key. Evidentiary standard is not standardized. Merely
descriptive=immediately conveys information about feature, function, or
characteristic. But generic? The thing being named, or if it’s a key aspect or
subgroup, which is where we start running into problems.

Possibilities: allow acquired distinctiveness for any
asserted mark; require acquired distinctiveness for any asserted mark
(requires legislative modification). Should TM registration be w/o much
examination? Allow people to file claims and then go from there.

Another: expand consideration of a “mixed record” where
there is some generic and some nongeneric use. Many people use “google” to mean
“use Google.” Could expand on that more.

Legal standard: preponderance in inter partes case; ex parte
move towards preponderance. She argues that they should go the other way: clear
and convincing for everything. Why? Because generic terms get no protection.
Should look for abandonment and fraud where we have a higher burden of proof.
Consider preclusion as well. W/genericness, we are talking about the same
thing, so preclusion would be appropriate.

Unprotectable generic terms should be precise, like apple for fruit (note that this is a subset). Not a key
aspect or subgroup. “Apple candy” is not generic for candy, it’s just a flavor/key
aspect. Should be descriptive.

Relevant consumer: perceptions can determine commercial
strength but the inputs are often the same as for conceptual strength—dictionaries
w/lower-case references. Keep up with the culture by considering social media. Evolving
norms of communication and branding both have no punctuation/capitalization:
lululemon.

Hughes: Agrees that generic means thing: “highly descriptive”
doctrine should be used to moderate this problem for things like apple candy.
Relevant consumers for determination of genericness should be different for
more narrow descriptiveness group of consumers. Singer was recaptured from
genericity, as was Goodyear (probably).

McKenna: disagree w/Hughes b/c categories aren’t found in
nature. Is diet soda a category or a subgroup? It’s market definition. Is apple
candy a thing? That has no abstract answer. In favor of calling more generic:
once you introduce secondary meaning, you’ve told defendants that the case will
cost hundreds of thousands or millions, whereas genericity is more easily
managed. Before Booking.com there was the competitive need test and that’s why
failure to function has had a resurgence.

Roberts: Nike just got SNKRS w/vowels removed—that’s the Booking
problem.

RT: [I agree on the subgroup issue: soup spoon; car is a
subset of vehicle; apple for fruit is a subgroup; key aspect may be another way
of saying market-defined subgroup.

Spectrum of descriptiveness/ “highly descriptive” category will
likely defeat your attempt unless you take more steps to put that off limits
too.

Clear and convincing: basis in statutory text? There’s a
common-law case for treating fraud differently but I don’t see that for
abandonment or genericity; the “harsh consequence” is the natural consequence
of choosing a generic term. (Not to mention that these days you can still get
unfair competition protection under §43(a), which is not the case for patents.)]

Deborah Gerhardt, Trade Dress Edges

Where does trade dress begin and end? The definition expanded
far beyond packaging/display. Color, product design. This matters b/c we’re supposed
to apply functionality for trade dress, and we often use Seabrook for
distinctiveness, whereas there aren’t many disclaimer practices for trade dress
and there are for word marks. So there are doctrinal differences.

Possibilities: (1) Trade dress a subset of TM (based on the statutory
language in 1127); (2) partially overlapping (Two Pesos, where text might be
included in some trade dress; INTA view of overall look and feel without
functionality); (3) Restatement view of distinct categories. But do you have to
apply functionality analysis if there’s a word involved?

PTO doesn’t use this categorization—it uses text, design,
sound, etc. Traditional/nontraditional is also unhelpful and does no doctrinal
work.

Tyler Ochoa: we call functionality genericity when it
applies to word marks. [Not sure that’s entirely true—the AOL “you’ve got mail”
case is functionality more than genericity.]

Trade dress got overexpansive; Two Pesos got cut back in
Wal-Mart in particular with the tertium quid versus product configuration/packaging.

A: in sound marks we do see genericity and functionality
merging—alarm sound.

RT: Consider substantial similarity—it’s the standard for
everything in © but we recognize that different genres may require different
analysis. Choral music requires experts to tell you what might count as similarity
of expression in choral music, etc. The value is in finding patterns and so I’m
comfortable with being in the subset box (1).

Betsy Rosenblatt: willing to go further—there are lots of
words that are informationally functional and should be denied registration for
that reason for relevant goods/services.

Roberts: what’s inside the “trade dress” circle? Are sounds and
smells trade dress, or are they something else?

[Things that can be inherently distinctive v. things that
can’t be as another important line?]

Sheff: identify where the distinction matters—functionality,
maybe; inherent distinctiveness not available for product design; practical
relevance: defining the unregistered trade dress is a big part of the job for
§43(a)—even though there may not be a doctrinal issue it is a very practical
one where we fight over how specifically we have to claim features.

A: Impetus: some sound marks are treated like text, and
others like product design—analytically unsatisfying. Rules for registering
text don’t work well.

from Blogger http://tushnet.blogspot.com/2023/08/ipsc-breakout-session-1.html

Posted in Uncategorized | Tagged , , , | Leave a comment

IPSC Opening Plenary Session

 Matthew Sag, Copyright Safety for Generative AI

Not addressing whether training is always fair use in every
circumstance; explain how generative AI fits w/in existing law (nonexpressive
uses) and identify best practices to make generative AI fairer.

Non expressive uses: reverse engineering, anti-plagiarism,
search plus text data mining, snippets. Although Authors Guild didn’t discuss
it, that was very much about machine learning—the endgame was more sophisticated
analysis using machine learning, not just frequency tables. His theory: rights
of © are defined w/r/t communication of original expression to the public.
Nonexpressive uses don’t involve human enjoyment of the original expression
contained in a work and don’t lead to other humans potentially enjoying that
original expression. Thus, nonexpressive uses don’t interfere w/the kind of
interest © is designed to protect, which is why they are such strong candidates
for fair use.

But is generative AI really the same? Are the outputs copies
of the training data? Copying takes place prior to training; converted into
tokens and training is a process of adjusting weights in the model, not copying
tokens. Info acquired is much more abstract than the training data. The output
is a novel synthesis, not just a cut and paste, usually combines abstract
latent features learned from training data.

But CS literature on extraction attacks exists: in
successful attacks, models may be trained on many duplicates of the same work;
images associated with unique text descriptions; ratio of model size to
training data is relatively large. Generally the extraction attacks fail; only
succeed in edge cases. These are real risks, but rare. More common: The Snoopy
problem: text to image models are set up to learn attributes of ©able
characters: b/c same text description paired w/relatively simple images that
vary only slightly. Not limited to characters; other images repeated w/ minor
variations and consistently tagged w/same keywords: Banksy’s girl holding a red
balloon.

Implications: too much memorization undermines arguments in
favor of fair use. Hard to argue it’s highly transformative if training data
come out as output. May also have implications under fourth factor. What to do?
Ten suggestions in paper, but key: (1) reasonable measures to deduplicate; (2)
reasonable measures in training and deployment to reduce probability of
infringement—curate/pre-processing training data; using reinforcement learning
through human feedback; installing restrictions on model outputs. (3) reasonable
measures to safeguard privacy interests. (4) detailed records of works used and
their provenance.

Sonia Katyal, A Trademark Theory of Rebranding

Lots of rebranding out there. Cultural and economic factors
(change in what the business does over time, including startup drift and
embrace then rejection of crypto). Practices are undertheorized and
underregulated. Not transparent/information asymmetry for consumers. Internal
contradiction in TM: rebranding could be characterized as contradiction b/t law
and marketplace: marketplace gives incentives to rebrand, given lack of legal
regulation thereof. A single user can obfuscate its past identity from its
present. Source concealment/distortion.

Most common reason: change of ownership or structure,
merger, acquisition, sponsorship change, shift from private to public, demerger

Change in corporate strategy—globalization or localization,
diversify or divest. Change in competitive position or external environment
(attracts the most commentary). TM doctrine assumes marks are chosen for
potential for perpetuity. Allows tacking of priority w/continuing commercial
impression. Material alteration requires new filing. This rule facilitates
information asymmetry that can harm consumers by adding information costs. Distortion:
expansion of boundaries by continuing commercial impression (actual TM
boundaries). Also identity concealment—Worldcom to MCI; organizational
misdescription—renaming, reorganization, shell companies; source obfuscation, where
FB rebrands to Meta as distraction; affiliative disinformation—broader rebranding
associated w social movements.

TM law should facilitate disclosure or it will fall behind
market.

Sheff: What about licensing/merchandising in this system? That
deprives consumers of info in the way that you’re talking about; the law used
to treat it as a kind of deception but now we all love it.

Sag: Why isn’t this like bankruptcy? Fresh start.

A: good for companies, not so good for consumers.

Alex Roberts, Multi-Level Lies: Distinctive feature is that
laypeople are making advertising claims to friends, social media followers,
acquaintances, etc. Sellers make money by selling product but also by recruiting
others. Exploitative: 99% make no profit/lose money; stuck w/unwanted
inventory; exploitative based on false promises of wealth and miracle products—the
seller gets free advertising. Not surprising that sellers make false claims—they’re
desperate to sell. Lack knowledge/training; rules aren’t intuitive, including
risks of sharing true but unrepresentative experience. Nondisparagement clauses,
some of which purport to bind family members. Indemnification clauses (likely
uncollectable, but still scary). Many contracts—77%–say sellers can only use
marketing claims or materials provided by company; 71% say other claims must be
pre-approved (that seems contradictory). 57% say sellers could be liable for
false etc. claims, but only 24% reference or explain specific rules.

Many actual sellers (convenience sample) make effectiveness
claims—80% almost always/half the time; 85% make testimonial claims; 73% make
data-based claims (lose 1.8 pounds/week); 86% make positive subjective claims;
78% make business opportunity claims. 59% were aware that laws/rules constrain the
claims they make, mostly made aware by training or other reps from company. Did
they influence how you advertise? Many people said yes, but many people skipped
the respondents—47% said they almost always follow the rules. Many expressed
uncertainty that the rules applied to them. 46% said desire to sell outweighed
desire to comply; didn’t expect enforcement. 37% said the company didn’t say anything
about restrictions on claims or said that there were no restrictions.

Takeaway: companies, not lay sellers, must be held liable
for false, misleading, or noncompliant claims disseminated by sellers. FTC and FDA
think this already!

More enforcement; more training for MLMs with interactive onboarding/continuing
education. Expand social media monitoring.

Contract issues: limiting arbitration and class action
waivers would help; classify sellers as employees? Platforms should enforce own
TOS against these claims.

Katyal: are the influencer rules different/should this be
folded in?

A: biggest difference is that influencers get paid by the
seller and MLM sellers don’t. Affiliate marketers get a cut of sales; that’s
similar to how MLM works, so it’s pretty easy to see how they fit in, but you don’t
really need that piece because FTC has said elsewhere that the companies are
liable for claims made by sellers—the case law doesn’t require the endorsement
piece to hold the company liable for the claims.

Q: endgame?

A: even with the ones that aren’t snake oil, and many are,
there are risks of false income claims that should be guarded against. FTC
could go harder against supplement market in general; FTC/FDA should team up
more often.

Christopher S. Yoo, Common Carriage and Social Media

Hating on social media is bipartisan. Turning to common
carriage analysis. Declare as matter of statutory announcement that they’re
common carriers and hope that makes the regulation constitutional, as in Fl and
Tex. Can that be right? No. Turner Broad. Sys. v. FCC says that the Court has
to assess those judgments. Thomas once said that labeling a regulation a common
carrier scheme “has no real First Amendment consequences.”

What about common law? Rationales are almost all debunked
but one works.

“Affected with a public interest.” That’s not enough. It’s
an empty category. Newspapers were critical for disseminating information, but
that doesn’t deprive them of 1A protection for editorial judgments.

“Monopoly power.” That’s historically not been true. The
root is not in 17th century English common law, but 20th century laws creating
public utilities. Even if that were the case, should it make a difference to
the 1A analysis? Not in Tornillo, even though most cities were one-newspaper
towns at the time.

“Transportation/communication.” This is a useless category.
Lumping things together doesn’t teach anything (Oliver Wendell Holmes). Too
general to be helpful. There are tons of communications media that aren’t
regarded as common carriers.

“Quid pro quo.” Section 230 as a quid pro quo. But not clear
that common carriers are the beneficiaries of 230. Another statute enacted at the
same time says “nothing in this section shall be construed to create
interactive computer services as common carriers or telecom carriers.” There’s
clearly some immunity for entities that aren’t common carriers.

“Holding oneself out as serving the entire public.” It’s an
antifraud test, but easily evaded. DC Circuit says that FB, Google, etc. don’t
hold themselves out as affording neutral, indiscriminate access and that net
neutrality didn’t apply to any services involving editorial judgment.

The real motivation: syllogism, not 1A analysis.

Major premise: old regimes like common carriage must be
constitutional.

Minor: new regulations of social media are like common
carriage.

Conclusion: new regulations ok.

Major premise is problematic; SCt has never resolved.
Precedents uphold access regulation only for media in which one actor exercises
physical, not economic, control that social media lack. Invoking common
carriage accomplishes nothing/serves as a distraction.

Lemley: What do you do with telephones? We clearly apply
that to telephones.

A: dial-a-porn cases can help answer. Both sets of cases say
that even a common carrier offering services, you can also offer video over
which you exercise complete discretion. You can be a common carrier for only part
of your services.

Lemley: but only b/c we put telephony and cable in different
buckets. Why not exercise discretion over how and under what circumstances we
deliver telephone calls?

A: is the logical implication that there are limits on that?
Yes.

Interestingly, neither Fl nor TX bars discrimination in the
ordinary sense—deplatforming and shadowbanning are not the same things. Not a
true common carrier regulation.

Chris Newman: nondiscrimination in common carriage is about
passage, not behavior on the vehicle/harassing other passengers.

A: agreed. The author of the 5th Circuit opinion said we
reject constitutional challenges to nondiscrimination laws, but that’s about
economic discrimination, not speech discrimination. That’s handwaving.

Nicholson Price, Empirical Studies of Medical AI Patents (w/
Mateo Aboy & Seth Raker)

Applications are up even after Bilski, etc. Grant rates
dipped but then went back up. 3 of top 5 patent applicants are the 3 biggest
MRI makers. Disclosure is only ok; universities do better. Predictions to
contrary underestimated the cleverness of patent lawyers. We’ll get lots of patents
anyway; people figure out ways over around and through doctrinal barriers.

from Blogger http://tushnet.blogspot.com/2023/08/ipsc-opening-plenary-session.html

Posted in Uncategorized | Tagged , , , , , , , | Leave a comment

poop bag seller’s “compostable” claims are plausibly … false

Natale v. 9199-4467 Quebec Inc., 2023 WL 4850531, No. 21-CV-6775
(JS)(SIL) (E.D.N.Y. Jul. 28, 2023)

Many lawsuits against “recyclable” claims have been
dismissed, but not this “compostable” one. Defendant sells “Earth Rated
Certified Compostable Poop Bags.” “On the packaging [of] the 60-count version
of the Product, Defendant represents that the Product is ‘Certified
Compostable.’ ” The packaging for the 105-count and the 225-count versions of
the Product are “identical in all respects except for the size” and likewise
state that they are “Certified Compostable.” Defendant’s website says that its
“certified compostable bags meet the ASTM D6400 standard for municipal
composting as well as the EN13432 Home and Industrial standards for
compostability.” It further says that the Product “is ‘certified for home
composting’ and is compostable at a ‘city compost’ facility.”

But: “On the back of the 60-count version of the Product,”
the packaging “includes a small print disclaimer in small font” stating:
“COMPOSTABLE IN INDUSTRIAL FACILITIES[.] Check locally, as these do not exist
in many communities.” The packaging also states “[n]ot suitable for backyard
composting.” A small print disclaimer on the side panel of the 60-count version
also says: “[s]hould only be disposed of in commercial composting facilities
where pet waste is accepted.” The 105-count and 225-count versions of the
Product also include small-print disclaimers stating: “Should only be disposed
of in commercial composting facilities where pet waste is accepted. These
facilities may not exist in your area. If you want to compost your pet waste in
a home compost, please ensure to only use the resulting compost on non-food
crops.” The disclaimers on the website require clicking a “Read more” tab; FAQs
don’t use relevant titles. Users must navigate to an innocuously titled FAQ:
“[h]ow should I dispose of the compostable poop bags” to access the
disclaimers. Plaintiffs alleged that “[n]o reasonable consumer would expect
that by clicking on ambiguously named or indiscriminate links, they would find
small print language on Defendant’s website … that would contain language
inconsistent with the representation that the Product is capable of being
composted.”

The FTC “has stated that ‘compostable’ claims on dog waste
products are ‘generally untrue,’ ” given that “dog waste cannot be composted
because it can contain harmful contaminants (e.g., E. Coli).” The EPA has
stated that “[e]ven in backyard composting … dog waste can contain harmful
parasites, bacteria, viruses, or pathogens.” Plaintiffs further alleged that
the phrase “if [the] city’s municipal composting accepts pet waste” was false
and misleading because “industrial composting of dog waste is not available in
the United States.” Plaintiffs alleged that “[n]o reasonable consumer would
expect that the small print language on the back and side panels of the Product
would contain language inconsistent with the representation that the Product is
capable of being composted” and that no reasonable consumer would “expect that
a ‘certified compostable’ dog waste bag would not be capable of being
composted.”

The FTC’s Green Guides use two relevant examples:

Example 2:

A garden center sells grass
clipping bags labelled as ‘Compostable in California Municipal Yard Trimmings
Composting Facilities.’ When the bags break down, however, they release toxins
into the compost. The claim is deceptive if the presence of these toxins
prevents the compost from being usable.

Example 4:

Nationally marketed lawn and leaf
bags state ‘compostable’ on each bag. The bags also feature text disclosing
that the bag is not designed for use in home compost piles. Yard trimmings
programs in many communities compost these bags, but such programs are not
available to a substantial majority of consumers or communities where the bag
is sold. The claim is deceptive because it likely conveys that composting
facilities are available to a substantial majority of consumers or communities.

The 60-count version sells approximately $0.15 per bag. Defendant’s
similar 120-bag product that is not certified compostable sells for approximately
$0.06 per bag.

Unsurprisingly, plaintiffs properly alleged economic injury
sufficient for standing. And they adequately pled deceptive acts/false advertising
under N.Y. G.B.L. Sections 349 & 350. They plausibly alleged lack of compliance
with the Green Guides, getting out of NY’s safe harbor provisions for when an
“act or practice is … subject to and complies with the rules and regulations
of, and the statutes administered by, the [FTC] or any other official
department, division, commission or agency of the United States.”

It was plausible that the disclaimers weren’t clearly and
prominently displayed both because they were on the side/rear and because they
contradicted the prominent “Certified Compostable” claim on the front, as well
as defendant’s admission in one place on its site that “industrial composting
of dog waste is not available in the United States.” There were further contradictions
in that the 60-count package said it wasn’t is not suitable for home composting
but the larger count versions state they are compostable at home, but not for
food crops. Regardless, plaintiffs also alleged that pet waste is not safe to
compost at all due to its release of harmful bacteria as it decomposes. This
was sufficient to survive a motion to dismiss.
“[W]here appropriate facilities are not merely limited, but are in fact
non-existent, the suggested language that customers should ‘check locally’ because
such facilities ‘do not exist in many communities,’ or that facilities ‘may not
exist in [the customer’s] area,’ is plausibly deceptive in that it suggest that
if consumers were to look for an appropriate facility they may find one, when,
in actuality, no such facilities exist.” This problem was compounded by the contradictory
disclaimers; if it wasn’t safe for backyard composting or eligible for
industrial composting, then it was plausibly deceptive because it wasn’t
compostable at all. The package didn’t explain what the ASTM standard meant or
why it would matter if the consumer couldn’t actually compost the product.

Warranty, fraud, and negligent misrepresentation claims also
survived.

from Blogger http://tushnet.blogspot.com/2023/08/poop-bag-sellers-compostable-claims-are.html

Posted in Uncategorized | Tagged , , | Leave a comment

allowing free “For Sale By Owner” ads doesn’t imply no agents will be involved

Picket Fence Preview, Inc. v. Zillow, Inc., 2023 WL 4852971,
No. 22-2066-cv (2d Cir. Jul. 31, 2023)

District court opinion discussed
(second) here
.  The district court
dismissed Picket Fence’s false advertising/unfair competition claims against
Zillow under the Vermont Consumer Protection Act and Lanham Act, and the court
of appeals affirmed.

Picket Fence is a For-Sale-By-Owner (FSBO) “publication
business” that permits private homeowners to list available properties directly
to potential buyers in exchange for a fee. Zillow provides an “online portal”
for the advertisement of property and realtor services to “the general public.”

Unlike Picket Fence, however, Zillow advertises that it
permits FSBO property listings on its website for free. Picket Fence alleged
that these claims were false. The problem was that, after a seller would post a
FSBO listing, Zillow would allegedly “divert potential buyers to its paying Premier
Agents” by “stripp[ing] out all contact information” for a FSBO listing’s owner
or by posting the FSBO owner’s contact information beneath an advertisement for
a Premier Agent’s services, inducing potential buyers into paying additional
charges. This contradicted the FSBO promise because a FSBO advertisement was
allegedly “one that allows a person to advertise their property so that
potential buyers can see the advertisement and contact the owner/seller
directly without the use of a third party intermediary.” By making Premier
Agents a part of the transaction, Picket Fence alleged, Zillow was falsely
advertising that it permitted FSBO listings for free.

The deception was allegedly that a FSBO seller would
perceive a “guarantee that, in addition to listing their property for free on
Zillow’s website, no real estate agent could represent a potential buyer or be
involved in any part of the potential transaction,” and therefore chose Zillow
over Picket Fence. [You can tell how this is going to go by the description of
the claim.]

The basic problem: “Zillow’s advertisement would not mislead
a consumer who was interpreting the message reasonably. Zillow simply
advertises that FSBO sellers can post for free, and that is true.” It made no
additional representations that Premier Agents would not be involved in FSBO
transactions, nor that FSBO buyers would not incur transaction costs. The
complaint even alleged that sometimes buyers of FSBO properties have agents,
which made Picket Fence’s interpretation unreasonable.

A predatory pricing claim also failed, as did an argument that
FSBO ads must contain no agent/intermediary involvement. This was an implicit
falsity argument, and the allegations in support of the consumer deception
element were:

Picket Fence had former Zillow For
Sale By Owner customers complain about the deception on Zillow and specifically
said had they known the truth about how Zillow operated its website and their
For-Sale-By-Owner advertisements, they would have chosen to advertise with
Picket Fence. Picket Fence is aware that For-Sale-By-Owners would ch[o]ose a
free advertisement … since they assumed a free advertisement [ ] would be a
cheaper alternative.

But these were conclusory allegations without supporting
detail, and anyway there wasn’t even implied falsity, since Zillow wasn’t
alleged to have required the use of an agent by FSBO sellers.

from Blogger http://tushnet.blogspot.com/2023/08/allowing-free-for-sale-by-owner-ads.html

Posted in Uncategorized | Tagged | Leave a comment

WaPo on gold advertising and right-wing media

 I’m quoted in the story.

from Blogger http://tushnet.blogspot.com/2023/07/wapo-on-gold-advertising-and-right-wing.html

Posted in Uncategorized | Tagged , | Leave a comment

Defendant’s belief its ads were effective is evidence of injury

Sandoz Inc. v. Amgen Inc., 2023
WL 4681569
,
No. 2:22-cv-05326-RGK-MARx
(C.D. Cal. Jun. 29, 2023)

Sandoz brought state and federal
false advertising claims against Amgen for its advertising of
Neulasta, a pegfilgrastim injection used to treat the
immunity-reducing side effects of chemotherapy, in particular the risk of the
life-threatening infection febrile neutropenia (FN), by stimulating the
production of neutrophils, a
type of
white blood cell that helps the body fight infections.

Thanks to its patents, Amgen enjoyed a temporary exclusivity period for pegfilgrastim injections until 2015. In 2014, Amgen introduced
Onpro, a new method for delivering Neulasta through an “on-body injector.” With
Onpro, patients could receive timed pesfilgrastim injections the day after
chemotherapy without returning to the healthcare facility. The first
pegfilgrastim biosimilar hit the market in November 2018, and would ultimately
be followed by five others, including
Sandoz’s
Ziextenzo in November 2019.

A few months after Ziextenzo
launched, Amgen
launched a multi-million-dollar ad
campaign to promote Onpro. These ads claimed that “Pegfilgrastim PFS resulted
in a significantly higher risk of FN vs. Onpro” and “[w]ith PFS, FN incidence
increased by 31% vs Onpro.” These ads were based on an obseivational study
Amgen
conducted itself, in an effort to remain competitive with
the emerging biosimilar market.
But the
FDA,
independent reviews at scientific journals, and even some of
Amgen’s
own employees criticized the advertising claims as
unsupported and misleading.
A second Amgen
study received similar criticism. But Amgen continues to run its ads, now with updated claims that
Onpro lowered the incidence of FN by 36% as compared to pegfilgrastim PFS based
on its new study.
Amgen saw the ads as successful, believing that they
increased sales and convinced customers not to switch to biosimilars.

Ziextenzo did not perform well at
launch
, but the true cause was disputed
.
Amgen argued that there was no impact because the ads didn’t refer to Sandoz or
Ziextenzo, and Sandoz couldn’t identify a single patient, prescriber, or
insurer
that would have used Ziextenzo but
chose Onpro because of
the
advertising
claims.
After all
: (1) Ziextenzo was not
the first biosimilar on the market; (2) Ziextenzo was not reimbursable by
Medicare; (3) Ziextenzo was more expensive than both Onpro and its biosimilar
competitors; and (4) the COVID-19 pandemic drove a higher demand for on-body
injectors like Onpro because on-body injectors minimized patients’ need to
travel to healthcare facilities.
But Sandoz’s experts claimed over $32
million in lost net profits even after accounting for these.

Injury: Damages and disgorgement under
the Lanham Act require injury (for false advertising, not trademark
infringement, despite the same statutory language covering both; no, I am not
going to stop pointing this out any time soon).
Proving an injury through lost sales data can be
challenging because lost sales are often “predicated on the independent decisions
of third parties; i.e., customers.” Thus, “[a] plaintiff who can’t produce lost
sales data may therefore establish an injury by creating a chain of inferences
showing how defendant’s false advertising could harm plaintiff’s business.” Such
an inference may be established through economic models using “actual market
experience and probable market behavior.”

The evidence here, including direct
competition between the parties, would allow a jury to reasonably infer injury:

Ziextenzo was
among the handful of pegfilgrastim biosimilar PFS products on the market in
late 2019.
According to Defendant’s internal
memoranda, the advertising campaign was designed to “optimally position Onpro in
[the] face of biosimilar competition.” These ads ultimately succeeded, driving
89,000 additional units by Defendant’s own estimates. From these facts, a
jury
could reasonably infer that the entire pegfilgrastim
biosimilar market lost sales as a direct result of Defendant’s advertising. And,
because Ziextenzo was one of those biosimilars, a jury could further infer that
Ziextenzo lost sales, thereby causing Plaintiff an injury.

Although some cases disparage
defendants’ own expectations and beliefs about causation as evidence of injury (in
false advertising cases; never in TM cases), I believe this is both the
majority and the correct rule. The court found Amgen’s evidence corroborated by
Sandoz’s experts,
who opined that the entire biosimilar
market suffered as a result of Defendant’s advertising.
Courts routinely find expert testimony sufficient evidence
of an injury to survive summary judgment. And economic analysis is a valid
means of proving an injury caused by false advertising.

Because the advertisements are
ongoing, there
was
also a
genuine dispute of fact as to the likelihood of future injury.

California law requires an “economic
injury”; there was also a material fact issue on that for the same reasons.

from Blogger http://tushnet.blogspot.com/2023/07/defendants-belief-its-ads-were.html

Posted in Uncategorized | Tagged , | Leave a comment

Former distributor’s continuing use of “authorized distributor” leads to TM and false advertising claims

Axon Enterprise, Inc. v. Luxury Home
Buyers, LLC, No. 2:20-cv-01344-JAD-VCF
,
|2023 WL
4636917
(
D. Nev. Jul. 19, 2023)

In what seems likely a missed
opportunity due to insufficient investment in the defense, the court grants
summary judgment against an argument that “Taser” is generic (quick quiz before
reading further: what is the generic name for a Taser device?) but also narrows
the issues somewhat; the larger infringement, cybersquatting, and false advertising
claims can’t be resolved on summary judgment.

Axon makes Taser “non-lethal
weapons” (but that can’t be the generic name—anything that encompasses a Taser
and a beanbag gun is clearly too broad). Defendant LHB is a former distributor
now selling
used Tasers that its owner
refurbishes in his home workshop. Axon
sued for infringement of the
Taser
word and design marks and for holding Taser-related
domain names for ransom.
Axon apparently characterizes its non-lethal
electric weapons as “conducted energy weapons.”

When it was an authorized Axon
distributor, LHB’s owner registered
various
domain names including taser.org and tasers.org to help it market Tasers
online. LHB currently owns 64 domain names containing references to Taser or
Axon Taser models.
And while
neither party knows exactly when their distributor relationship ended, they
agree that it ceased sometime around 2000.
” Does that sound like the
claims against the domain names might be lached?

On websites, emails, and mailers,
LHB uses
Axon’s Taser character, stylized
word, and design marks, often in proximity to its own marks. On several of its
websites, LHB also makes representations that it is an “Authorized TASER®
Distributor” and that “TASER® is a Trademark of the Mister Stungun.”

Its marketing also focuses on the
superiority of the Taser X26E CEW over other models
—that is of course
the refurbished model it sells, while Axon has moved on—
stating that the X26E “wield[s] the highest degree of
takedown power of total and absolutely unsurpassed effectiveness[;]” “offers
the highest degree of takedown power ever available with the same level of
safety[;]” “has the most powerful technology and stopping force[;] “lasts for
over 20 years—and works every time[;]” and has “twice the power” of the X26P
CEW.
LHB also advertises that its products
are “factory refurbished,” “professionally refurbished,” “thoroughly tested,”
“refurbished to the highest standard,” “completely refurbished” to “work like
new,” “even better than new,” and reprogrammed “with the latest software.”

Axon was entitled to summary
judgment on genericity. LHB offered only
two news
articles and a Ninth Circuit opinion that use the word “Taser” without the
trademark symbol
:

The mere fact
that two article authors and a Ninth Circuit panel utilized the mark without a
corresponding trademark symbol does not show as a matter of law that the
primary significance of “Taser” to consumers is as a type of good rather than a
source identifier. And the context of each reference was to refer to an Axon
product or to distinguish other products as alternatives to Axon’s weapons.

Even if they were generic uses, two
articles and one opinion weren’t sufficient to overcome the “strong presumption”
of validity of a registered mark.

Likely confusion: Obviously, this
is a nominative use. But is it a nominative fair use?
Toyota Motor Sales v. Tabari asks whether “(1) the product was ‘readily identifiable’
without use of the mark; (2) defendant used more of the mark than necessary; or
(3) defendant falsely suggested [it] was sponsored or endorsed by the trademark
holder.”

The court rejected Axon’s argument
that LHB could have identified its products by calling them CEWs; they were
Taser brand products. However, it used more of the marks than reasonably
necessary, favoring Axon (the court seems to be treating this as a balancing
test, to be finalized in the third factor). The court applies the non-empirical
but fairness-based line of 9th Circuit cases stating that using logos and not
just names risks confusion. (When I see these claims I think about all the
businesses using Facebook, Twitter, LinkedIn etc. logos on their materials to
identify their social media accounts. Does anyone think that increases the
likelihood of confusion over affiliation? Just as with first sale, there is an
unambiguous truth—I have a legit product to sell, I have an account on this
site—coupled with a less-significant possibility of confusion about whether
there’s a greater relationship than that. I don’t think using the logo
guarantees confusion, but the context of social media may be much more
clarifying than the context of resales.)

Most importantly, there were
genuine issues of fact about whether LHB suggested
Axon’s sponsorship or endorsement. LHB argued that
it
avoided consumer confusion by fully disclosing that
its products are refurbished and by maintaining the basic nature of the Taser
through the refurbishment process.
“A
xon responds
that the first-sale doctrine isn’t dispositive of this prong because
affiliation confusion can still exist for disclosed refurbished products.

 

As the Ninth Circuit held in Sebastian International v. Longs Drug Stores,
first sale
doctrine “is not rendered
inapplicable merely because consumers erroneously believe the reseller is affiliated
with or authorized by the producer.” The Sebastian court thus held that,
“[w]hen a purchaser resells a trademarked article under the producer’s
trademark, and nothing more, there is no actionable misrepresentation.”

Still, that’s limited to using the
trademark on a resold article and its immediate packaging, but not using stylized
marks
and logos on advertising materials. Axon didn’t seek to
enjoin the sales of refurbished Tasers.

Axon’s evidence of actual confusion was three emails from various police officers and personnel
inquiring about any affiliation between Axon and LHB, as well as declarations
from
two officers
that they
were confused about an affiliation between the parties.
LHB pointed out
that it
markets to thousands of police
departments,
and one
declaration
only states that he was under the belief that LHB “could be affiliated with
Axon
.” Still, that was enough to create a genuine issue of fact. [Note
that the cases are just divided on this—inquiries and uncertainty often indicate
that the inquirers correctly understood that they needed to know more before
concluding that there was an affiliation. Compare this to the treatment of ambiguity
in advertising law—outside of trademark, courts make consumers work much
harder.]

The context of the use also
mattered. Axon pointed to
LHB’s
phrases such as “100% certified to work like new,” false description of itself
as “an [a]uthorized TASER® distributor”
(this was, LHB argued, an
oversight on some of its websites left over from when that was true),
use of Axon’s
stylized mark in the top left corner of every single page on
accreditedsecurity.com, and incorporation of Axon’s globe/bolt logo into that
same page.
It argued
that LHB’s
disclaimers
were
ineffective at curing confusion
because of their placement alone—they appear in small font at the bottom of
LHB’s website and are thus “buried and easy to miss.”
However, the
disclaimers were not ineffective as a matter of law. Whether LHB suggested
affiliation was an issue of fact.

False advertising: As noted above,
LHB made superiority claims for the model it sold; claims that its products
were
“factory refurbished,” “professionally refurbished,”
“thoroughly tested,” “refurbished to the highest standard,” “completely
refurbished,” “work like new,” and reprogrammed “with the latest software”
;
and
affiliation statements that it is an “[a]uthorized
TASER® [d]istributor” and “TASER® is a [t]rademark of the Mister Stungun.”

The product superiority claims
failed. Although these statements weren’t puffery, but specific and measurable,
they weren’t shown to be false either. Although LHB admitted it never tested
that model against others, it relied on “
two media
articles, his personal opinions, stories from his customers, and unspecified
google searches.

But this wasn’t a “tests prove”
case. [Did the statements inherently suggest the existence of scientific
research backing them up? I might’ve gone the other way on this.] Thus, showing
that reliable studies didn’t support the claims didn’t suffice to falsify them.
Axon didn’t submit any evidence of falsity. The closest it got was an expert
report
stating that “Axon has established a
5-year useful life for its CEW products and strongly discourages … use of
CEWs beyond their 5-year useful life.”
But a
manufacturer’s strong recommendation of a product’s useful lifespan does not
show that the device cannot last for more than 20 years.

Refurbishment quality: Axon argued that LHB’s
Tasers cannot be “factory refurbished” because the process takes place only in
its
principal’s
home or in the homes of his
independent contractors; nor “professionally refurbished” because
he
has no degree or expertise in mechanical engineering; nor
“thoroughly tested” because LHB does not run independent testing other than
superficial inspection; nor “refurbished to the highest standard” because LHB
identified no standards it was using; nor “completely refurbished” to “work
like new” because Tasers are sonically welded together such that their internal
components cannot be examined or replaced. And finally, while Axon agrees that
LHB’s Tasers might be reprogrammed “with the latest software,” it argues that
such a claim is misleading because the last X26E firmware update was in 2014
and
LHB
does not have access to the most
recent updates for two of the other Taser models he sells
.

LHB responded that each Taser “undergoes several aesthetic and functionality
inspections” in which he “installs new batteries, new firmware, cleans any
internal carbon build-up in the front cartridge, clears any error codes, and
ensures each element of the [display] functions properly.”
Its principal
maintains a “designated space [that] LHB references
as a ‘factory’ area to perform the refurbishment process.”

The court found that reasonable jurors
could disagree about the “subjective” meanings of the claim. [Doesn’t that mean
that evidence of consumer deception is required, in the absence of literal
falsity?]

Affiliation statements: Everybody
agrees that neither
“[a]uthorized TASER® [d]istributor”
nor
“TASER® is a [t]rademark of the Mister Stungun”
is true. But Axon still needs to show deception and materiality. Literal
falsity leads to a presumption of materiality and deception, and “[n]
othing in the record suggests that those presumptions
should not apply here.
” [This might be a good case for why there shouldn’t
always be such a presumption, although I think it should still exist in many
cases; neither “always” nor “never,” the more recent judicial trend, is ideal.]

But Axon wasn’t just seeking a
permanent injunction; it sought compensatory damages, but pointed to no evidence
of actual injury or damages from the false affiliation statements. It lost
summary judgment on damages but won summary judgment as to injunctive relief.

Trial only on
LHB’s refurbishing-quality statements.

Nevada deceptive trade practices:
Similar results, but somewhat different remedies for the affiliation statements.
LHB knew it was aware the distributor relationship was over well before Axon
filed suit.
Nevada’s law allows a court to require a liable party “to pay to the aggrieved party
damages on all profits derived from the knowing and willful engagement in a
deceptive trade practice and treble damages on all damages suffered by reason
of” that practice.
And its

consumer-fraud statute requires a court to award a deceptive-trade-practices
claimant “any damages that the claimant has sustained; any equitable relief
that the court deems appropriate; and the claimant’s costs in the action and
reasonable attorney’s fees.”
Thus, Axon could recover damages and
attorney’s fees but would have to prove the amount.

Then, surprisingly reversing the result
on the product superiority statements in the Lanham Act context, the court says
that although there’s no evidence of falsity, “
Nevada law
imposes liability for disparaging claims based on true-but-misleading
statements
,” so that would have to go to trial. But the Lanham Act also
imposes liability for true-but-misleading statements; it just requires evidence
that consumers were misled to do so—here, about the nature and quality of LHB’s
supporting evidence. Having a different result on the state law claim is
conceptually weird but does highlight that traditional common-law claims are
more likely to be decided on vibes, whereas Lanham Act false advertising has adopted
a technocratic, probabilistic structure that often demands survey or other
empirical evidence.

The court also denied summary
judgment on the ACPA claim, even though one of
LHB’s
websites
listed
its various Taser-related domains
with a headline banner labeled “Domain Names for Sale.”
The court agreed
that bad faith could arise after registration of a domain name. Still, there
were genuine disputes over bad faith because the prior distributorship, and
current sales of refurbished Tasers, weighed against things like LHB’s offer to
sell the domain names to Axon. Even redirecting four of the contested domains
to porn sites didn’t sufficiently show intent to tarnish the Taser mark for
summary judgment purposes.

Laches (I wondered!): Although Axon had knowledge of some of the contested domains since
at least 1999,
LHB didn’t fully analyze the laches standard or
offer evidence that it suffered prejudice from delay. Summary
judgment for LHB on laches denied.

from Blogger http://tushnet.blogspot.com/2023/07/former-distributors-continuing-use-of.html

Posted in Uncategorized | Tagged , | Leave a comment

over aggressive partial dissent, 11th Cir. allows some class claims against Ford “track ready” claims to proceed

Tershakovec v. Ford Motor Company, Inc., — F.4th —-,
2023 WL 4377585, No. 22-10575 (11th Cir. Jul. 7, 2023)

Discussion
of district court opinion
. Ford advertised its Shelby GT350 Mustang as
“track ready.” “But some Shelby models weren’t equipped for long track runs,
and when the cars overheated, they would rapidly decelerate. A group of Shelby
owners sued Ford on various state-law fraud theories and sought class
certification, which the district court granted in substantial part.” Ford appealed
and the court of appeals tinkered with the certification, over a dissent that
thought that enforcing consumer protection laws in this case would violate the Constitution
in multiple ways (edging close to the claim that the class action mechanism
violates Article III).

The key question was predominance, which depended on whether
the specific state laws at issue required proof of reliance, whether reliance
could be presumed, and if so under what circumstances.

As for the facts:

The Shelby is an upgrade of the
standard Mustang and, importantly here, was advertised as “an all-day track car
that’s also street legal.” Track-capability refers to the vehicle’s capacity to
perform at higher-than-normal speeds in a controlled environment—like, say, on
a racetrack. Track-readiness was a central theme in Ford’s Shelby advertising.

Yet, of the five Shelby trims, the Base and Technology trims
lacked “transmission and differential coolers,” a feature—originally included
as standard on all Shelbys—that is designed to prevent engine overheating.
Without them, the Shelbys compensate at high RPMs by reverting to “limp mode,” which
reduces the vehicle’s power, speed, and performance to avoid engine damage—and
is inconsistent with track-capability.

“On appeal, twelve separate claims remain, arising under the
laws of seven states: California, Florida, Missouri, New York, Tennessee,
Texas, and Washington.”

The parties focused on reliance, so the majority did as
well, dismissing the dissent’s claim that reliance and causation are inherently
intertwined as inconsistent with governing state law. See, e.g., Carriuolo v.
Gen. Motors Co., 823 F.3d 977, 983, 986 (11th Cir. 2016) (Florida) (holding
that plaintiffs “need not show actual reliance on the representation or
omission at issue,” even when causation is an element). Thus the majority also
declined to address the manifold constitutional claims made by the dissent.

The majority did, however, find that the district court
erred by overgeneralizing the set of cases in which reliance can be presumed to
those cases where a defendant’s representations to the entire class were
uniform. But this can only be done if the underlying state law allows for it. “Affirmatively
proving reliance is a very individualized inquiry, the kind that would
predominate over other common questions in a class action. By contrast, where
the presumption of reliance applies, it does so generally and can therefore be
resolved on a class-wide basis.”

And then the majority does something very weird, albeit (it
says) prompted by the parties’ concessions. It says that presuming reliance
from materiality often is only appropriate where the cause of action is
omission-based, relying on cases decided under the federal securities laws. I
have no idea why those are relevant (and indeed the majority seems to
understand that California, at least, does not take that position, agreeing
with the district court that a uniform material misrepresentation can lead to a
presumption of reliance).

From that, the court then rejected plaintiffs’ argument that
this was an omissions case; at its core, this case was about
misrepresentations, not omissions. And it rejected plaintiffs’ invocation of Klay
v. Humana, 382 F.3d 1241 (11th Cir. 2004), abrogated in part on other grounds
by Bridge v. Phoenix Bond & Indem. Co., 553 U.S. 639 (2008), for the
proposition that common evidence about misrepresentations can be used to prove
reliance on a class-wide basis, because there the misrepresentation that a HMO
would pay for procedures was the central factor driving the transaction. “While
one who provides services in exchange for a payment relies only on the payment
guarantee, a purchaser of a car may choose to rely on any of a number of
marketing and branding representations.” (I mean, so might the provider of
medical procedures, especially in a world where they can sue the patient for
any underpayment; this bright line does not seem consistent with many state law
decisions I’ve seen and seems to underweight the idea of material
misrepresentation in particular.)

With that out of the way, claims based on state laws that
didn’t require reliance could proceed on a classwide basis, and claims based on
state laws that didn’t presume reliance couldn’t. For claims based on state
laws that sometimes presume reliance, the majority examined whether reliance
could be presumed.

No reliance required: Florida Deceptive and Unfair Trade Practices
Act; N.Y. Gen. Bus. Law § 349(a); Washington’s consumer-fraud statute; and the Missouri
Merchandising Practices Act.

No presumption of reliance, therefore no certification: Texas
Deceptive Trade Practices-Consumer Protect Act and common-law fraud claims
under Washington, New York, and

Tennessee law.

Causes of action that require proof of reliance but allow it
to be presumed in certain circumstances: The usual
California claims
, both statutory and common-law, fell in this category. On
remand, the district court should consider whether “the defendant so
pervasively disseminated material misrepresentations that all plaintiffs must
have been exposed to them.” If so, certification would be appropriate.

But California and Texas classes for breach of implied
warranty and violations of the federal Magnuson-Moss Warranty Act required
further analysis. The district court first needed to decide “whether California
and Texas law require pre-suit notice, an opportunity to cure, and
manifestation of the defect.”

Superiority: “Ford fears that jurors will have to remember
testimony from multiple witnesses, all while keeping track of the class
members’ states, the applicable common-law rules and statutes, and burdens of
proof.” The district court thought that “appropriate jury instructions” and
“multiple verdict forms that tick through the [varying] elements of [the]
certified state class[es]’ statutory and common law fraud claims” would
suffice, but the majority was more worried. Given that some of the claims had
been kicked out, on remand the court “should consider the manageability
challenges anew on remand and should more clearly articulate a plan for
addressing them to ensure that the difficulties of managing the class action do
not impede the fair and efficient adjudication of the case.”

Senior Judge Tjoflat concurred as to the claims that were
tossed out and dissented as to the claims kept alive, engaging in a
wide-ranging rejection of state law precedents as unconstitutional or
inapposite or just wrong or all of the above. I didn’t know that federal courts
(other
than the Supreme Court
) were supposed to tell state courts they interpreted
state legislation wrong, and I suspect that’s one reason the majority doesn’t
engage with the dissent much. We’re obviously in a period of great
constitutional doctrinal change, and so disregarding positions as “off the wall”
is a risky game, but I will just sketch out what Judge Tjoflat says are the
constitutional problems rather than recount all the arguments state by state.  

The FTCA declares unlawful “[u]nfair methods of competition
in or affecting commerce, and unfair or deceptive acts or practices in or
affecting commerce.” That’s vague, but the FTC tells businesses they’re
violating the Act before punishment (I … didn’t think that was the standard for
avoiding unconstitutional vagueness). Importantly [for its constitutionality],
the FTCA doesn’t allow for damages or a private right of action. (!!!! Judge
Tjoflat mentions civil penalties, but doesn’t explain why in his view they are ok.)

Even when state laws explicitly refer to FTC standards,
then, they have different constitutional constraints because they authorize
private actions for backward-looking damages. But vagueness when barring
misrepresentation is less troubling than vagueness when barring unfairness,
including because misrepresentation comes with an inherent causal mechanism.
Plus, prior decisions under the statute can limit vagueness:  

First, we can look to prior
decisions under the statute. “Unfair business practice” might not in itself
tell a cruise ship company that it cannot charge customers an additional fee,
label it a “port charge,” then pocket some of that extra money as profit. But a
previous case decided by a court under the consumer protection statute dealing
with that situation would.

Or we can provide notice by using the common law definition
of fraudulent misrepresentation, where the common law provides the notice. (Treating
the common law as clear and natural and non-evolving is an important part of
the conservative judicial project, but it’s used so incoherently that I’ve
never been able to develop a full account.)

Either way, when there’s a misrepresentation, reliance is
required (I believe option 1 required reliance because the baseline was
requiring reliance so any previous case must have either imposed a reliance
requirement or announced a change.) Harm only occurs if there’s reliance (Judge
Tjoflat is no fan of price premium theories). Here, “[s]ome of the class
members (1) may not have seen the advertisements at issue, (2) may not have
wanted a track-ready car, or (3) wanted merely to collect the car without ever
driving it around the track.” They couldn’t have relied on the alleged
misrepresentation. [Especially for (3), that’s a bold factual claim.] No
reliance means no causation, and none of the statutes at issue here explicitly
disclaims reliance.

All those state court cases talking about contributing cause
versus but-for cause, or presuming reliance from materiality, don’t count,
because “by reading out a reliance element in all cases, a court usurps the
legislature’s power and attempts to bind future courts in a way inconsistent
with our conception of judicial power.” “Our” here is doing a lot of work, not
just in an ideological way but also in terms of putting Article III constraints
on state courts.

Certifying a class here therefore poses problems of free
speech, due process, separation of powers, and standing. [Oh look, the Article
III challenge to the class action mechanism I’ve been waiting for has arrived!]

Free speech: “While the First Amendment does not protect
untruthful commercial speech, the judicial elimination of a causation element
makes a speaker liable for speech with or without the speech actually harming
anyone. This chills protected speech.” It would be fine under the First
Amendment to enjoin deceptive commercial speakers or hold them liable for the
actual damage they cause, but not to assess damages even for consumers who
weren’t deceived. [And statutory damages? Punitives? Statutory penalties?] Even
though a consumer protection law only prohibits deceptive commercial speech, without
reliance, “any rational businessperson would stand so far away from the
ill-defined line between outlawed advertising and permissible advertising—thus
chilling protected speech—to avoid the potentially catastrophic consequences of
damages to all.” [No citation to cases about chilling commercial speech,
because the current doctrine is that commercial speech is hardy enough to
resist chill.] Prophylactically prohibiting “potentially misleading—and
therefore protected—speech” “goes well beyond that necessary to further a
state’s interest in protecting consumers from misrepresentation.” [That doesn’t
even follow! “Potentially misleading” is a new concept and not the same as “misleading”—or
at least it is currently.]

Due process: bound up with the above, but worse with a class
action. Where reliance ought to be an element of a claim, class actions violate
due process because unnamed plaintiffs might get relief without having a
meritorious individual claim. “Much as a court eliminating causation from the
traditional elements of negligence would deprive a defendant of property
without notice—thus denying the defendant due process—so would excusing the
reliance (and therefore causation) element in these state consumer protection
statutes.” It would be a judicial taking! [One thing that fascinates me is the
on/off characterization of causation, reliance, damages, etc. If one thinks
that presumptions and probabilities are appropriate subjects of legal rules,
this imagined field of infinite liability becomes much more bounded.]

Anyway, without reliance and thus causation, there’s also an
Article III standing problem. An objective test for a forward-looking injunction
is fine, but not for damages. “[E]ven though ‘Congress [or a state legislature]
may elevate harms that exist in the real world before [the legislature]
recognized them to actionable legal status, it may not simply enact an injury
into existence.’ ” TransUnion. Plus, the state shouldn’t be able to
delegate enforcement power into private hands because they aren’t
democratically accountable.

And finally, there’s a separation of powers problem because
any state court that announces that a state statute doesn’t require showing
reliance in a misrepresentation case has usurped the legislature’s power and
rewritten the statute. This makes the free speech problem worse because state
legislatures have the police power to protect citizens from injury, but courts
don’t.

And now we get to presumptions: a rebuttable presumption of
reliance can’t possibly apply to any of the claims in this case. Such
presumptions are only allowed when the party with the burden of rebuttal has
better access to the evidence, and consumers have better access than sellers to
evidence about what motivated them. [This is probably untrue as a matter of
consumer psychology and marketing knowledge, and it also doesn’t seem to me to
describe the full range of rebuttable presumptions that exist, either. Does the
TMA’s rebuttable presumption of irreparable harm to trademark owners put the
burden on the party who has most access to the evidence? This seems like “common
law as fixed, natural, and just as I think it should be” again.] Plus, allowing
Ford to rebut the presumption would make a class action unmanageable.

So it would have to be a conclusive presumption, which has all
the problems above: California courts shouldn’t have created it either for the
statutes or for the common law (even if it were correct about the statutory standard
“as a linguistic matter”). State courts holding otherwise aren’t entitled to
full faith and credit because they don’t “wrestle” with the constitutional
questions (and resolve them as Judge Tjoflat wants).

Likewise, though Florida’s FDUTPA explicitly requires courts
to interpret the statute by giving “ ‘due consideration and great weight’ to
Federal Trade Commission and federal court interpretations of section 5(a)(1)
of the Federal Trade Commission Act,” it makes “no sense” to say, as Florida
courts have, that because the FTC Act allows suits without proving reliance, so
should the FDUTPA. “How the FTC Act treats reliance has nothing to say about
the FDUTPA’s damages provision,” since the FTCA doesn’t allow private damages,
only prospective relief or “civil damages.” The court here should also ignore the
Michigan Supreme Court because it gave short shrift to due process concerns in
interpreting its own law.

Judge Tjoflat has been on the bench for decades, but I do
wonder whether he’d have written this opinion before a few years ago, given the
swing-for-the-fences approach many judges in his circuit are now willing to
take.

from Blogger http://tushnet.blogspot.com/2023/07/over-aggressive-partial-dissent-11th.html

Posted in Uncategorized | Tagged , , , , | Leave a comment

Covid-19 Act gives government more options in proceeding against supplement seller

U.S. v. Nepute, 2023 WL 4623089, No.
4:21-CV-437 RLW
(E.D. Mo. Jul. 19, 2023)

The US sued Nepute (a chiropractor)
and Quickwork (a company of which he is a member/co-manager). for deceptive
advertising of dietary supplements in violation of the FTCA and
the COVID-19 Consumer Protection Act. Here, the
court excluded/limited Nepute’s proposed experts, denied partial summary
judgment to Nepute, and granted partial summary judgment to the US on a few
issues, including whether the challenged materials were ads.

Since early
2020, Defendant Nepute and Quickwork have used several platforms, including
social media, emails, and radio, to tout the purported benefits of Vitamin D
and zinc and to promote Wellness Warrior supplements.
” The government
alleged that Nepute made false and misleading claims about the supplements,
including that
Wellness Warrior supplements
containing Vitamin D and/or zinc are effective for the treatment, cure,
prevention, or mitigation of coronavirus disease 2019 (“COVID-19”), and that
they provide equal or better protection against COVID-19 than available
vaccines.
Given its powers under the COVID-19 Act, the government sought
not just a permanent injunction, but damages, including recission/restitution/disgorgement,
as well as civil penalties.

The court excluded the testimony of
Dr. Parks, who had (as relevant)
a Ph.D. in
cellular and molecular biology in 1999
but hadn’t
conducted academic or peer-reviewed research since 2000;
none of this research related to zinc or any dietary supplement, or to covid.
 Since 2004,
she worked as
a high school teacher at a
homeschool co-op in Michigan.
Her education and research were
insufficient to qualify her t
o testify as
to the clinical benefits of zinc and the prevention and treatment of COVID-19
.

Defendant Nepute also couldn’t
testify as an expert (as opposed to as a fact witness). He has a 2007 Doctor of
Chiropractic degree and some post-doctorate training, including
certification as a Doctor of Natural Medicine and as a Certified Nutrition Specialist. He conducted no studies or research, led/participated
in no
clinical trials, and published no academic papers in any peer-reviewed journal. The primary focus of his practice is the treatment of neuromusculoskeletal
complaints and fatigue
; he
does not
treat disease in his chiropractic practice, and there
was no record of
any experience treating infectious diseases or
covid. He lacked
the education, training, and
experience to testify regarding the clinical benefits of Vitamin D and zinc to
prevent or treat COVID-19.

As a fact witness, the government
agreed that he could
supply what he claims is “the
scientific basis upon which he made the alleged misstatements”
for the
purpose of assessing whether he had sufficient substantiation for his claims.
 But he
couldn’t
testify as an expert on whether such
evidence
was
sufficient to satisfy the relevant
scientific community that Vitamin D and zinc can treat and/or prevent COVID-19.

Were the publications at issue ads?
In general, advertisements provide consumers with
information regarding products or services for sale in commerce.
Under Section 12 of the FTC Act, an “advertisement” is a
publication that has the “tendency or capability to induce the sale of [a]
product.” Publications “designed to convey the point that consumption of a
particular product [will convey a health benefit] are clearly likely to induce
the purchase of that product.” It
was
undisputed
that Nepute used several platforms to share the purported benefits of Vitamin D
and zinc and his Wellness Warrior supplements
, including
Facebook videos, emails, and FM radio shows. Along
with the claims, consumers were directed to websites where they could get a “free”
bottle and buy additional bottles.

Nepute argued that these were just
educational materials and argued that,
“in many
cases, listeners were directed to the Quickwork website[s] for the express
purpose of providing further health information.”
Because the websites
do more than simply sell vitamins and supplements – they
are “interconnected with the exposition of ideas about how to live a healthy
life” –
he argued that references to the
websites in the publications didn’t make them ads, and
that his content was “infused with political speech
.” First, Nepute didn’t offer a First Amendment
defense in the answer and couldn’t do so now. But even if he had, his speech
was not entitled to First Amendment protection: The publications were
commercial speech, and there were fact issues on falsity/misleadingness, for
which he could be held liable.

The evidence didn’t support the
claim that the websites were used as educational references. E.g.:

So here’s
what I want you to do. Go to freevitamindeals.com – that’s freevitamindeals.com
so that you can get the products that you need. I’m giving you a bottle of zinc
for free, a bottle of D3 for free. I need you to buy that immune pack. You’d be
silly not to get it. If you don’t want to, that’s fine. But I’m just telling
you what you need to do. According to the research, it’s what you should be
doing.

By the delivering the message about
the benefits of Vitamin D and zinc
in
conjunction with providing the websites where viewers and readers could
purchase Vitamin D and zinc, the videos and emails were clearly likely to
induce the purchase of these products.

The radio shows were a closer call;
they were two hours long and weren’t limited to
Vitamin D and zinc, or even COVID-19, vaccines, or other
available treatments.
But the parts that the government was challenging
were ads: “
During the radio programs themselves
– outside the scheduled commercial breaks – Defendant Nepute made statements
that the consumption of Vitamin D and/or zinc will provide certain health
benefits; he delivered his message in conjunction with providing websites where
listeners could purchase Wellness Warrior Vitamin D and zinc supplements; and
he instructed, either explicitly or by clear implication, that listeners should
purchase vitamins and/or supplements.

The government can show either
falsity/misleadingness or lack of substantiation to prevail. The government was
entitled to summary judgment on the issue that there is
no substantiation for representing that Vitamin D and/or zinc provide equal or
better protection against COVID-19 than the vaccines, to the extent Nepute made
such a claim in his advertisements
. (He argued that he didn’t, and that
he was just attacking the efficacy of the vaccines without making comparisons.
Sure.) It also received summary judgment that there was no substantiation for a
claim
that zinc is effective for preventing and treating
COVID-19
.

Materiality: there was no dispute
that the challenged claims were material. “
This would be
especially true during the COVID-19 pandemic.
” Also summary judgment for
the government.

However, there was a fact issue of
whether all the ads at issue made those claims.  

The videos
and radio shows appear to have been unscripted, impromptu performances, which
at times were rambling and disorganized. Certainly, Defendant Nepute made
assertions about Vitamin D, zinc, COVID-19, and the vaccines, among other
things, in his advertisements, but he often jumped from topic to topic and did
not make connections between his statements. Furthermore, some of the
representations he made about Vitamin D and zinc were vague or ambiguous.
Drawing inferences most favorable to Defendant Nepute, the Court finds the
issue of whether representations made in each of the 64 advertisements created
the net impression that either (1) Vitamin D and/or zinc provide equal or
better protection against COVID-19, or (2) that zinc is effective for preventing
and/or treating COVID-19, is a matter for the Government’s presentation of
evidence at trial and determination by the jury.

Nepute’s individual liability: An individual is liable for a company’s violations of the
FTC Act if he (1) “either participated directly in the deceptive acts or
practices or had the authority to control them”; and (2) “either knew or should
have known about the deceptive practices.”
It was undisputed that he both
controlled and participated in the practices and knew about the contents, so
the government also got summary judgment here.  

Number of violations: The government
calculate
d
that the 16 Facebook videos, 33
emails, and 15 radio shows have been disseminated 10,175,234 times for purposes
of the COVID-19 Act,
apparently by adding
the number of “views” for the videos on Facebook, the
number of email addresses to which the email advertisements were sent, and the
number of “views” the radio shows had after they were posted on Facebook and
CloutHub.
But there were factual disputes about how “views” are counted
on Facebook, and the court signaled its discomfort with that kind of raw
counting. Even if each unlawful letter in a mass mailing is a separate
violation, “[p]
osting videos and radio shows on
social media is entirely different than calling consumers or sending letters,
as the latter are targeted forms of communication where
the number of intended recipients is readily calculable.
” [That would
seem to give a premium to using mass/social media to disseminate false ads,
which seems like the opposite of the right incentive.] The court wanted more
from the government when it asked the jury to find liability for a number of
violations.

Nepute argued that the government
wasn’t entitled to civil penalties
under the
COVID-19 Act, because the evidence
didn’t
support a finding that he knowingly violated the Act.
The relevant standard required a showing that
Nepute acted
“with actual knowledge or knowledge fairly implied on the basis of objective
circumstances that such act is unfair or deceptive and is prohibited” by the
COVID-19 Act. Knowledge can be “fairly implied” where “a reasonable and prudent
man under the circumstances would have known of the existence” of a statute or
regulation, and “that the action charged violated that provision.”

The COVID-19 Act was enacted on December 27, 2020. On March
30, 2021, the FTC sent a letter enclosing a copy of the COVID-19 Act to Nepute’s
attorney, informing Nepute that the Act “provides that marketers who make
deceptive claims about the treatment, cure, prevention, or mitigation of
COVID-19 are subject to a civil penalty[.]”
It
filed suit on April 15, 2021. Nepute argued that he
didn’t know about the
COVID-19 Act before March 30, 2021, and he had no knowledge that he might be
in violation of it prior to the filing of this lawsuit.
But, in May
2020,
the FTC sent a letter to him stating he was unlawfully advertising that supplements
Vitamin C and D can treat or prevent COVID-19. It is undisputed that
he
was advised in this letter to review “all other claims
for your products and services and immediately cease making claims that are not
supported by competent and reliable scientific evidence.”
Also there was
evidence that
Nepute had marketed vitamins and
supplements for at least a decade, and that he kept abreast of the news and
participated in legislative decision-making related to Vitamin D, zinc, and
COVID-19.
A jury could accept that “
a reasonably
prudent person, with over a decade of experience in vitamin and supplement
marketing, and who advertises on behalf of a multimillion-dollar supplement
enterprise, would have been aware of a major federal consumer protection
statute implicating his business and marketing.

 

from Blogger http://tushnet.blogspot.com/2023/07/covid-19-act-gives-government-more.html

Posted in Uncategorized | Tagged , , | Leave a comment

“24 Hour” cosmetics could be misleading as to sunscreen effect

Zimmerman v. L’Oréal USA, Inc., 2023
WL 4564552, No. 22-cv-07609-HSG (N.D. Cal. Jul. 17, 2023)

This is another lawsuit
over “24 Hour” cosmetics
, this time focusing on the fact that the
sunscreen in the products needs to be reapplied every 2 hours, making it more a
2-hour beauty line. The foundation’s front label statements claim it provides
“Up to 24HR Breathable Texture,” “Up to 24H Fresh Wear,” and “Sunscreen Broad
Spectrum SPF 25,” but the drug facts panel, located underneath a peel-back
sticker on the back label, directs users to “reapply at least every 2 hours”
for sunscreen use.

Zimmerman didn’t
have standing for two identified, unpurchased products—L’Oréal Pro-Glow
Foundation and Lancôme Foundation—where the alleged misrepresentations were not
substantially similar to L’Oréal Infallible Foundation, the product Zimmerman
purchased. L’Oréal Pro-Glow Foundation advertises “Up to 24HR Foundation,” and
Lancôme Foundation advertises “Up to 24H Color Wear & Comfort.” As for
other products, the court couldn’t assess substantial similarity without images
or detailed descriptions of the labels.

Zimmerman had standing
to seek injunctive relief, because she might not be able to tell if the labels
are accurate if L’Oréal changes the SPF protection duration; or, if L’Oréal alters
the front label to state that the SPF only lasts two hours and lowers the
price, she might be willing to pay. (I’m not sure the first is technically
possible, but I also don’t think it’s unreasonable for consumers not to know
that.)

There was no FDCA
preemption.  

And it was
plausible that a reasonable consumer could be deceived. L’Oréal argued that the
24-hour statements clearly referred only to cosmetic benefits, but the court
disagreed; “a reasonable consumer could believe the statements also include SPF
protection and would not see the reapplication instructions at the time of
purchase because they are buried underneath a sticker.” Where “a front label is
ambiguous, the ambiguity can be resolved by reference to the back label.” The
front label statements were ambiguous; “24H Fresh Wear” and “24HR Breathable
Texture” could be interpreted to include sunscreen protection. But it wasn’t
clear that the ambiguity could be resolved by reading the back. “The Court
cannot conclude as a matter of law that a reasonable consumer would peel back
the label in the store, before purchasing the product, to find and read these
instructions.”

from Blogger http://tushnet.blogspot.com/2023/07/24-hour-cosmetics-could-be-misleading.html

Posted in Uncategorized | Tagged , | Leave a comment